Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination

Shaun Truelove, Claire P. Smith, Michelle Qin, Luke C. Mullany, Rebecca K. Borchering, Justin Lessler, Katriona Shea, Emily Howerton, Lucie Contamin, John Levander, Jessica Salerno, Harry Hochheiser, Matt Kinsey, Kate Tallaksen, Shelby Wilson, Lauren Shin, Kaitlin Rainwater‐Lovett, Joseph C. Lemaitre, Juan Dent, Joshua Kaminsky, Elizabeth C. Lee, Javier Perez‐Saez, Alison L. Hill, D. Karlen, Matteo Chinazzi, Jessica T. Davis, Kunpeng Mu, Xinyue Xiong, Ana Pastore y Piontti, Alessandro Vespignani, Ajitesh Srivastava, Przemyslaw Porebski, Srinivasan Venkatramanan, Aniruddha Adiga, Bryan Lewis, Brian Klahn, Joseph Outten, James Schlitt, Patrick Corbett, Pyrros A. Telionis, Lijing Wang, Akhil Sai Peddireddy, Benjamin Hurt, Jiangzhuo Chen, Anil Vullikanti, Madhav Marathe, Stefan Hoops, Parantapa Bhattacharya, Dustin Machi, Shi Chen, Rajib Paul, Daniel Janies, Jean‐Claude Thill, Marta Galanti, Teresa K. Yamana, Sen Pei, Jeffrey Shaman, Nicholas G Reich, Jessica M. Healy, Rachel B. Slayton, Matthew Biggerstaff, Michael A. Johansson, Michael C. Runge, Cécile ViboudmedRxiv 2021 · DOI

Abstract

In mid-2021, the United States faced a critical juncture as the highly transmissible SARS-CoV-2 Delta variant emerged alongside plateauing vaccination rates. This study, utilizing an ensemble of nine mechanistic models, projected a significant COVID-19 resurgence for the second half of 2021. The findings indicated that while the Delta variant made a national wave likely, the scale of the impact—measured in hospitalizations and deaths—was heavily dependent on state-level vaccination coverage. Increasing national vaccination from 70% to 80% was projected to avert approximately 1.5 million cases and 21,000 deaths.

Introduction

By the summer of 2021, early successes in the U.S. vaccination campaign had driven COVID-19 cases to their lowest levels since the pandemic's onset. This progress prompted many jurisdictions to lift non-pharmaceutical interventions (NPIs), such as mask mandates and social distancing. However, this period of relative calm was threatened by two converging factors: the rapid spread of the Delta variant and a slowdown in vaccine uptake due to hesitancy.

This research sought to quantify the potential resurgence by modeling the interaction between variant transmissibility and vaccination levels. The goal was to identify geographic vulnerabilities and determine the potential "buffer" provided by higher vaccination rates as the country moved toward school and business reopenings in the fall.

Methodology: The Ensemble Approach

The study leveraged the COVID-19 Scenario Modeling Hub, a collaborative framework aggregating projections from nine independent modeling teams, including researchers from Johns Hopkins University, Penn State, and Northeastern University.

Scenario Matrix

To account for uncertainty, the researchers employed a 2x2 scenario matrix focusing on two primary variables:

  1. Transmissibility: Delta was modeled as either 40% (low impact) or 60% (high impact) more transmissible than the previously dominant Alpha variant.
  2. Vaccination Uptake: National saturation was set at either 70% (high hesitancy) or 80% (low hesitancy) of the eligible population.

Projections were combined using an equally-weighted linear opinion pool. To ensure robustness, the ensemble trimmed the most extreme high and low outliers. These projections were then benchmarked against the Winter 2020-2021 peak to provide a relative scale of the anticipated resurgence.

Data Integration

The models were calibrated using several key data streams:

  • Epidemiological Trends: Case, hospitalization, and death data from the Johns Hopkins University CSSE and federal (HHS/CDC) databases.
  • Vaccination Metrics: State-level uptake and age-specific coverage from the CDC.
  • Behavioral Insights: Vaccine sentiment and hesitancy data from the Carnegie Mellon University Delphi Group and the U.S. Census Bureau’s Pulse Survey.

Key Insights

The Reality of High Transmissibility

As the study progressed, observed data from July 2021 began to track with or even exceed the most pessimistic scenarios (60% increased transmissibility). This suggested that Delta’s transmission advantage was at the upper end of estimates, or that the rapid removal of NPIs accelerated the spread beyond initial model assumptions.

Vaccination as a Mitigating Factor

The models demonstrated that while high vaccination rates could not entirely prevent a Delta-driven wave, they served as a powerful "temper." In high-coverage scenarios, the wave peaked lower and subsided more quickly. There was a strong negative correlation (Pearson’s $r = -0.66$) between a state's vaccination coverage and its projected cumulative deaths, underscoring the direct link between public health policy and mortality.

Geographic Disparities

The resurgence was projected to be highly heterogeneous. States with lower vaccination rates (e.g., Louisiana, Mississippi, Alabama) were expected to see peaks rivaling their previous winter highs. Conversely, high-vaccination states (e.g., Massachusetts, Vermont) were projected to experience much milder rebounds.

Results and Projections

  • National Peak: Under the most pessimistic scenario (70% vaccination, 60% increased transmissibility), the ensemble projected a peak of 414,000 weekly cases and 5,900 weekly deaths by mid-to-late September 2021.
  • Cumulative Burden: This scenario estimated approximately 7.5 million cases and 96,000 deaths between July 2021 and January 2022.
  • The Impact of 10%: Improving vaccination coverage from 70% to 80% was projected to avert 1.5 million cases (a 20% reduction) and 21,000 deaths (a 22% reduction).
  • Case Fatality Ratio (CFR): Notably, the CFR was projected to be lower than in 2020 across all scenarios, primarily due to high vaccine coverage among the most vulnerable populations (ages 65+).

Limitations

The authors identified several challenges in long-term pandemic modeling:

  • Behavioral Responses: Models struggle to predict how individuals change their behavior (e.g., resuming masking) in response to rising local transmission.
  • Waning Immunity: The duration of protection from both vaccines and prior infections was still being characterized during the study period.
  • Pediatric Dynamics: The models did not fully account for the lack of vaccine eligibility for children under 12, a factor that became significant during school reopenings.

Conclusion

The study’s projections emphasized that the Delta wave's severity was not a fixed outcome but was significantly influenced by vaccination efforts. The findings highlighted the critical need for renewed efforts to increase vaccine uptake, particularly in states with lower coverage, to limit transmission and prevent avoidable deaths.

Summary updated

Abstract

Summary What is already known about this topic? The highly transmissible SARS-CoV-2 Delta variant has begun to cause increases in cases, hospitalizations, and deaths in parts of the United States. With slowed vaccination uptake, this novel variant is expected to increase the risk of pandemic resurgence in the US in July—December 2021. What is added by this report? Data from nine mechanistic models project substantial resurgences of COVID-19 across the US resulting from the more transmissible Delta variant. These resurgences, which have now been observed in most states, were projected to occur across most of the US, coinciding with school and business reopening. Reaching higher vaccine coverage in July—December 2021 reduces the size and duration of the projected resurgence substantially. The expected impact of the outbreak is largely concentrated in a subset of states with lower vaccination coverage. What are the implications for public health practice? Renewed efforts to increase vaccination uptake are critical to limiting transmission and disease, particularly in states with lower current vaccination coverage. Reaching higher vaccination goals in the coming months can potentially avert 1.5 million cases and 21,000 deaths and improve the ability to safely resume social contacts, and educational and business activities. Continued or renewed non-pharmaceutical interventions, including masking, can also help limit transmission, particularly as schools and businesses reopen.
BibTeX
@misc{truelove2021projected,
  author = {Shaun Truelove and Claire P. Smith and Michelle Qin and Luke C. Mullany and Rebecca K. Borchering and Justin Lessler and Katriona Shea and Emily Howerton and Lucie Contamin and John Levander and Jessica Salerno and Harry Hochheiser and Matt Kinsey and Kate Tallaksen and Shelby Wilson and Lauren Shin and Kaitlin Rainwater‐Lovett and Joseph C. Lemaitre and Juan Dent and Joshua Kaminsky and Elizabeth C. Lee and Javier Perez‐Saez and Alison L. Hill and D. Karlen and Matteo Chinazzi and Jessica T. Davis and Kunpeng Mu and Xinyue Xiong and Ana Pastore y Piontti and Alessandro Vespignani and Ajitesh Srivastava and Przemyslaw Porebski and Srinivasan Venkatramanan and Aniruddha Adiga and Bryan Lewis and Brian Klahn and Joseph Outten and James Schlitt and Patrick Corbett and Pyrros A. Telionis and Lijing Wang and Akhil Sai Peddireddy and Benjamin Hurt and Jiangzhuo Chen and Anil Vullikanti and Madhav Marathe and Stefan Hoops and Parantapa Bhattacharya and Dustin Machi and Shi Chen and Rajib Paul and Daniel Janies and Jean‐Claude Thill and Marta Galanti and Teresa K. Yamana and Sen Pei and Jeffrey Shaman and Nicholas G Reich and Jessica M. Healy and Rachel B. Slayton and Matthew Biggerstaff and Michael A. Johansson and Michael C. Runge and Cécile Viboud},
  title = {{Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination}},
  year = {2021},
  doi = {10.1101/2021.08.28.21262748},
  howpublished = {medRxiv},
}
Figure